No / T-type Ca2+ channels (Cav3.1, 3.2 and 3.3) strongly influence proliferation of various cell types, including vascular smooth muscle cells (VSMCs) and certain cancers. We have recently shown that the gasotransmitter carbon monoxide (CO) inhibits T-type Ca2+ channels and, in so doing, attenuates proliferation of VSMC. We have also shown that the T-type Ca2+ channel Cav3.2 is selectively inhibited by hydrogen sulfide (H2S) whilst the other channel isoforms (Cav3.1 and Cav3.3) are unaffected. Here, we explored whether inhibition of Cav3.2 by H2S could account for the anti-proliferative effects of this gasotransmitter. H2S suppressed proliferation in HEK293 cells expressing Cav3.2, as predicted by our previous observations. However, H2S was similarly effective in suppressing proliferation in wild type (non-transfected) HEK293 cells and those expressing the H2S insensitive channel, Cav3.1. Further studies demonstrated that T-type Ca2+ channels in the smooth muscle cell line A7r5 and in human coronary VSMCs strongly influenced proliferation. In both cell types, H2S caused a concentration-dependent inhibition of proliferation, yet by far the dominant T-type Ca2+ channel isoform was the H2S-insensitive channel, Cav3.1. Our data indicate that inhibition of T-type Ca2+ channel-mediated proliferation by H2S is independent of the channels’ sensitivity to H2S. / This work was supported by the British Heart Foundation (PG/11/84/29146).

No / T-type Ca2+ channels are a distinct family of low voltage-activated Ca2+ channels which serve many roles in different tissues. Several studies have implicated them, for example, in the adaptive responses to chronic hypoxia in the cardiovascular and endocrine systems. Hydrogen sulfide (H2S) was more recently discovered as an important signalling molecule involved in many functions, including O2 sensing. Since ion channels are emerging as an important family of target proteins for modulation by H2S, and both T-type Ca2+ channels and H2S are involved in cellular responses to hypoxia, we have investigated whether recombinant and native T-type Ca2+ channels are a target for modulation by H2S. Using patch-clamp electrophysiology, we demonstrate that the H2S donor, NaHS, selectively inhibits Cav3.2 T-type Ca2+ channels heterologously expressed in HEK293 cells, whilst Cav3.1 and Cav3.3 channels were unaffected. Sensitivity of Cav3.2 channels to H2S required the presence of the redox-sensitive extracellular residue H191, which is also required for tonic binding of Zn2+ to this channel. Chelation of Zn2+ using TPEN prevented channel inhibition by H2S. H2S also selectively inhibited native T-type channels (primarily Cav3.2) in sensory dorsal root ganglion neurons. Our data demonstrate a novel target for H2S regulation, the T-type Ca2+ channel Cav3.2. Results have important implications for the proposed pro-nociceptive effects of this gasotransmitter. Implications for the control of cellular responses to hypoxia await further study.

No / T-type Ca2+ channels regulate proliferation in a number of tissue types, including vascular smooth muscle and various cancers. In such tissues, up-regulation of the inducible enzyme heme oxygenase-1 (HO-1) is often observed, and hypoxia is a key factor in its induction. HO-1 degrades heme to generate carbon monoxide (CO) along with Fe2+ and biliverdin. Since CO is increasingly recognized as a regulator of ion channels (Peers et al. 2015), we have explored the possibility that it may regulate proliferation via modulation of T-type Ca2+ channels. Whole-cell patch-clamp recordings revealed that CO (applied as the dissolved gas or via CORM donors) inhibited all 3 isoforms of T-type Ca2+ channels (Cav3.1-3.3) when expressed in HEK293 cells with similar IC50 values, and induction of HO-1 expression also suppressed T-type currents (Boycott et al. 2013). CO/HO-1 induction also suppressed the elevated basal [Ca2+ ]i in cells expressing these channels and reduced their proliferative rate to levels seen in non-transfected control cells (Duckles et al. 2015). Proliferation of vascular smooth muscle cells (both A7r5 and human saphenous vein cells) was also suppressed either by T-type Ca2+ channel inhibitors (mibefradil and NNC 55-0396), HO-1 induction or application of CO. Effects of these blockers and CO were non additive. Although L-type Ca2+ channels were also sensitive to CO (Scragg et al. 2008), they did not influence proliferation. Our data suggest that HO-1 acts to control proliferation via CO modulation of T-type Ca2+ channels.

The role of T-type calcium channels (TTCCs) in the heart is unclear. TTCCs are transiently expressed throughout the neonatal heart during a period of rapid cardiac development. A few weeks postnatally, TTCCs are no longer found in ventricular myocytes (VMs) and calcium influx via TTCCs (ICa,T) is only detected in the SA node and Purkinje system. However, pathologic cardiac stress is associated with re-expression of TTCCs in VMs. Whether ICa,T in this setting promotes cardiac growth or exacerbates cardiac function is a topic of debate. The focus of this thesis work was to examine the effect of TTCC re-expression in the normal and diseased myocardium. Our experiments were performed in a transgenic mouse model with inducible, cardiac-specific expression of α1G TTCCs. While both the α1G and α1H TTCC subtypes re-appear during cardiac disease, we specifically evaluated the effects of α1G TTCCs since mRNA levels of this TTCC subtype are markedly elevated during cardiac pathology. We found that transgenic mice with α1G overexpression had robust ICa,T with biophysical properties similar to those published in previous studies. α1G mice had a small increase in cardiac function and showed no evidence of cardiac histopathology or increased mortality. These findings were in contrast to the phenotype of transgenic mice with augmented L-type calcium channel (LTCC) activity secondary to overexpression of the β2a regulatory subunit. While the magnitude of calcium influx in α1G and β2a VMs was similar, we found that cardiac contractility of β2a mice was significantly greater than α1G mice. Also, β2a mice had significant cardiac fibrosis, myocyte death, and premature lethality compared to the benign phenotype of α1G mice. We showed that the phenotypic differences are likely related to the differential spatial localization of T- and LTCCs. Whereas α1G TTCCs were principally localized to the surface sarcolemma, LTCCs were primarily found in the transverse tubules in close proximity to the sites of sarcoplasmic reticulum calcium release. We evaluated the effect of TTCC expression during cardiac disease by inducing myocardial infarction (MI) in α1G mice. Acutely (1-week post MI), α1G mice showed similar worsening of cardiac function and mortality rates compared to control post-infarct mice. However, α1G hearts had smaller infarct sizes which correlated with increased Akt and NFAT activation in α1G than control hearts. After chronic heart failure, i.e. 7- weeks post-infarction, α1G hearts had significant hypertrophic response as determined by increased HW/BW ratio, myocyte cross-sectional area, as well as NFAT and Akt activity. Finally, α1G mice had a small survival benefit than control mice, which while statistically non-significant, suggests that TTCC re-expression does not exacerbate cardiac function as hypothesized by some investigators. We conclude that TTCCs play a minimal role in cardiac function and activate pro-survival signaling pathways in the myocardium. / Physiology

Le traitement et la gestion de la douleur sont depuis toujours une priorité pour le corps médical. Malgré leur importance pour la qualité de vie, les analgésiques couramment utilisés possèdent un ratio bénéfice/risque faible. La recherche de nouveaux concepts thérapeutiques pour lutter contre la douleur est donc une priorité. Afin de répondre à ce besoin, il faut d'abord comprendre les mécanismes de la perception de la douleur ainsi que, plus globalement, ceux permettant de percevoir son environnement. Dans ce contexte, de nombreuses études ont mis en évidence l'implication du canal calcique à bas seuil Cav3.2 dans les voies de la transmission de l'information douloureuse. Il représente donc une cible de choix pour le traitement de la douleur mais l'identité des neurones exprimant ces canaux ainsi que la fonction de Cav3.2 dans la physiologie des neurones sensoriels étaient jusqu'à présent inconnues. Au cours de cette thèse nous avons dans un premier temps décrit un nouvel inhibiteur des canaux calciques à bas seuil : le TTA-A2. Nous avons ainsi démontré que le TTA-A2 est un inhibiteur spécifique des canaux Cav3.1, Cav3.2, et Cav3.3. Il permet de diminuer l'excitabilité des neurones sensoriels exprimant Cav3.2, ce qui provoque une analgésie sur des animaux sains et pathologiques. Dans un deuxième temps nous nous sommes servis de ce nouvel outil en parallèle d'un nouveau modèle murin possédant une étiquette fluorescente (Knock in GFP) sur le canal Cav3.2 pour explorer la localisation et la fonction de Cav3.2 dans les neurones sensoriels. Nous avons ainsi découvert que Cav3.2 est exprimé dans des mécanorécepteurs à bas seuil impliqués dans la perception des stimuli mécaniques et thermiques nocifs ou non-nocifs. Le canal en lui-même se trouve aux endroits clés de la genèse et de la propagation du message nerveux périphérique, et module le seuil et la vitesse de conduction des potentiels d'action. Replacé dans le contexte de la bibliographie, l'ensemble de nos résultats montre que Cav3.2 permet de donner la modalité à bas seuil aux neurones l'exprimant. / Pain management and treatment have always been a priority for life quality. Despite this fact, analgesics commonly used present a bad benefice/risk ratio. Discovery of new therapeutic concepts to fight pain is highly required. To complete this task, we first need to better understand pain perception mechanisms, and more globally, mechanisms involved in the perception of our environment. In this context, numerous studies have shown that low threshold calcium channels Cav3.2 are involved in pain information transmission. Thus, it represents a good target for the treatment of pain. However, neuronal identity of Cav3.2-expressing sensory neurons and Cav3.2 functions in neuronal physiology are unknown. During this PhD we first described a new low voltage activated channel antagonist named TTA-A2. We demonstrated that TTA-A2 is a powerful nanomolar specific agonist of Cav3.1, Cav3.2 and Cav3.3. This molecule is able to reduce excitability in sensory neurons expressing Cav3.2, and is able to generate a strong analgesic effect on naive and pathologic animals. In the other part of this PhD, we used this new tool combined to a new transgenic mouse that expressed Cav3.2 tagged with a fluorescent protein (Knock-in GFP). With these new tools we discovered that Cav3.2 is expressed in low threshold mechanoreceptors involved in detection of painful and non painful mechanical and thermal stimuli. Cav3.2 itself is expressed at key localisations that allow action potential generation and propagation, and modulate threshold and speed conduction of action potential. Taken together, these results show that Cav3.2 gives the “low threshold” modality to neurons.

Les plantes médicinales constituent un réservoir important de substances naturelles pour la découverte de nouvelles molécules thérapeutiques. L’intérêt de ce travail est d'explorer le potentiel thérapeutique des plantes médicinales connues pour leurs vertus neuromodulatrices et potentiellement d’intérêt pour le traitement de maladies neurologiques, y compris l’épilepsie, en étudiant leur capacité à cibler l’activité des canaux calciques de type T qui jouent un rôle important dans l’hyperexcitabilité neuronale et la physiopathologie des épilepsies. Le premier objectif de ma thèse était d’étudier l’effet des extraits de plantes méditerranéennes ; Lavandula stoechas, Rosmarinus officinalis et Peganum harmala, ainsi que leurs principes actifs ; le linalol, l’acide rosmarinique et l’harmaline, respectivement, sur des courants calciques de type T en utilisant la technique patch-clamp en configuration cellule-entière. Les enregistrements électrophysiologiques à partir de cellules HEK-293 exprimant les canaux T montrent que la lavande, le romarin et l’harmal réduisent significativement les courants de type T sur la gamme de potentiel membranaire testée. Les produits naturels arrivent à déplacer l'état stable d’inactivation vers des potentiels de membrane plus négatifs et certains (Peganum harmala) accélèrent significativement la cinétique d'inactivation des canaux T. Le deuxième objectif était d’étudier l’effet anticonvulsivant et/ou antiépileptique de ces plantes et du TTA-A2 ; un bloqueur sélectif des canaux T, sur un modèle animal d’épilepsie. Nos résultats valident le PTZ et la 4-AP comme inducteurs de crises chez le poisson zèbre, ces deux modèles permettant le criblage pour des molécules anticonvulsivantes et/ou antiépileptiques. Nos résultats montrent que le romarin, la lavande ainsi que le TTA-A2 inhibent les crises pseudo-épileptiques chez ces deux modèles. Dans l’ensemble, ce projet suggère que les canaux T seraient impliqués dans les propriétés neuroprotectrices et anticonvulsivantes des plantes médicinales étudiées et valide le rôle des plantes médicinales comme source intéressante de produits thérapeutiques. / Medicinal plants represent an interesting reservoir of natural substances for the discovery of new therapeutic molecules. The interest of this work is to explore the therapeutic potential of medicinal plants, which are known for their neuromodulation effects, by studying their ability to target the activity of T-type calcium channels which play a major role in neuronal hyperexcitability and the pathophysiology of epilepsy and other neurological diseases.The first objective of my thesis was to study the effect of Mediterranean plant extracts; Lavandula stoechas, Rosmarinus officinalis and Peganum harmala and their active ingredients; linalool, rosmarinic acid and harmaline, respectively, on T-type calcium currents using the patch clamp technique in whole-cell configuration. Electrophysiological recordings from HEK-293 cells expressing T-type channels show that lavender, rosemary and Harmal significantly reduce T-type currents over the potential range tested. The natural products shifted steady-state inactivation towards more negative membrane potentials and some plants (Peganum harmala) significantly accelerate the inactivation kinetics of T-type channels. The second objective was to study the anticonvulsant / antiepileptic activity of these plants as well as TTA-A2, a selective T-type channel blocker, in an epilepsy model in zebrafish. Our results validate the PTZ and 4-AP as inducers of convulsions in zebrafish and both models could be used to screen for anticonvulsant and/or antiepileptic molecules. Our results show that rosemary, lavender and TTA-A2 inhibit seizures-like activity in these two models. Overall, this project suggests that T-type channels are involved in the neuroprotective and anticonvulsant properties of the studied medicinal plants and validates the role of medicinal plants as a valuable source of therapeutic products.

Doctor of Philosophy / Department of Chemistry / Duy H. Hua / Three research projects are described in this dissertation, and they are: (i) discovery of piperidine derivatives as T-type calcium channel inhibitors for the treatment of epilepsy and neuropathic pain and as protein disulfide isomerase inhibitors for the treatment of influenza viral infection; (ii) discovery of peptide-based calcitonin gene-related peptide receptor antagonists for the treatment of inflammatory pain; and (iii) synthesis of substituted 6-(dimethylamino)-2-phenylisoindolin-1-ones for the inhibition of luciferase. T-type calcium channels are important regulators of nervous system, and upregulated T-type calcium channel activities have been found to link to various types of neurological disorders, such as epilepsy and neuropathic pain. To discover novel T-type calcium channel blockers, a series of 1,4-disubstituted piperidine derivatives were designed and synthesized. Among them, compound 1-4 was found to be a good T-type calcium channel inhibitor with an IC₅₀ of 1 nM for Ca[subscript v]3.2 inhibition. It also showed 86% suppression of seizure induced death in mice and good in vivo analgesic effects on both thermal and mechanical pain thresholds in Spared Nerve Injury rat models. Therefore 1-4 can potentially be used as a T-type calcium channel blocker in the treatment of epilepsy and neuropathic pain. Influenza is a respiratory viral infection. Since viruses rely on host cell proteins for their entry, survival and replication, development of drugs targeting host cell proteins has identified as an effective strategy in controlling viral infections. We synthesized a series of 1,4-disubstituted piperidine derivatives for the inhibition of protein disulfide isomerase enzyme and influenza. Among them, 1-29 was found to possess strong anti-influenza activity (EC₅₀ = 2.5 µM). This suggests the potential use of piperidine scaffold in designing anti-influenza drugs in future. Calcitonin gene-related peptide (CGRP) receptor antagonism has been identified as a successful approach for the treatment of inflammatory pain. Therefore, a novel class of peptide antagonists of CGRP receptor was synthesized and screened for their binding affinities to the CGRP receptor and their analgesic effects on inflammatory-induced pain in rats. Among them, peptide 2-3 showed a higher binding affinity towards the CGRP receptor than previously reported peptide antagonists and exhibited analgesic effects up to 2 h in both Aδ and c-fiber pain tests. Therefore 2-3 indicates its potential use as a CGRP receptor antagonist in the treatment of inflammatory pain. Firefly luciferase is commonly used as a reporter in cells expressing a luciferase gene or its enzymatic activity under the control of a promoter of interest to assess its transcriptional activity. It has been found that some molecules such as molecules with carboxylic acid moiety can directly inhibit luciferase activity in cells. However, it is suggested that carboxylic acid moiety of the compounds may also be associated with side reactions in cells. Therefore, to study whether carboxylic acid moiety causes side effects, we designed two probe molecules, 3-1 and 3-2. Synthesis of probe molecule 3-2 is discussed. Synthesis of probe molecule 3-1 and further investigation of its luciferase inhibition will therefore be useful to understand the toxicity of carboxylic acid containing drugs in future.

De nombreuses études expérimentales montrent que les canaux calciques activés par la dépolarisation membranaire, tout particulièrement les canaux calciques de type T (canaux T), jouent un rôle important dans la physiopathologie des épilepsies. Il existe trois isoformes des canaux T, Cav3.1, Cav3.2 et Cav3.3, toutes exprimées au niveau neuronal. De manière classique, c'est dans l'épilepsie absence où les canaux T ont été le plus étudiés. Les canaux T jouent également un rôle dans des modèles d'épilepsie partielle secondairement généralisée, comme le modèle pilocarpine qui mime l'épilepsie du lobe temporal (ELT). Jusqu'à présent ces canaux ne possédaient pas de pharmacologie spécifique, mais plusieurs molécules récemment synthétisées, en particulier le TTA-A2, apparaissent sélectives des canaux T. Le premier objectif de ma thèse était d'étudier l'implication des canaux T dans l'épileptogenèse. Pour cela nous avons traité des souris au TTA-A2 pendant la phase de latence du modèle pilocarpine (modèle ELT). Nos conditions expérimentales ne nous ont pas permis de conclure quant à une action protectrice du TTA-A2 dans ce modèle. Le deuxième objectif était d'étudier l'effet du TTA-A2 sur des modèles murins de convulsions généralisées : le modèle du Maximal Electroshock Seizure (MES) et le modèle pentylènetétrazole (PTZ). Deux lignées de souris inactivées pour les isoformes Cav3.1 ou Cav3.2 (KO Cav3.1 et KO Cav3.2) ont également été caractérisées dans cette étude. Nous montrons que le TTA-A2 réduit l'apparition des crises toniques dans le modèle MES et que les souris KO Cav3.1 sont également protégées, suggérant un rôle prépondérant des canaux Cav3.1 dans le développement des crises toniques. / Numerous experimental studies show that calcium channels activated by membrane depolarization, especially T-type calcium channels (T-channels), play an important role in the physiopathology of epilepsy. There are three T-channels isoforms, Cav3.1, Cav3.2 and Cav3.3, all expressed in neuronal level. Conventionally, T-channels were the most studied in absence epilepsy. T-channels are also involved in partial secondarily generalized epilepsy models, as the pilocarpine model that mimics temporal lobe epilepsy (TLE).Up to now, there was no specific pharmacology for this channels, but several molecules have recently been synthesized, particularly TTA-A2, appearing selective T-channels. The first goal of my thesis was to study the T-channels involvement in epileptogenesis. For this purpose we treated mice with TTA-A2 during the silent phase of the pilocarpine model (TLE model). Our experimental conditions do not allow us to conclude about a possible protective action of TTA-A2 on this model. The second goal was to study TTA-A2 effects on mice models of generalized seizures: the Maximal Electroshock model (MES) and the pentylenetetrazole model (PTZ). Two mice strains knock-out for Cav3.1 or Cav3.2 (KO Cav3.1 and KO Cav3.2) have also been characterized in this study. We show that the TTA-A2 reduces the appearance of tonic seizures in the MES model and the KO Cav3.1 mice are also protected, suggesting a preponderant role of Cav3.1 channels in the development of tonic seizures.

nÃo hà / Esta tese de doutorado apresenta duas novas topologias de conversores CA-CC com uso de neutro comum: conversor de cinco nÃveis intercalado e conversor de cinco nÃveis tipo T. AlÃm disso, uma nova forma de implementaÃÃo da tÃcnica de controle indireto da corrente (Indirect Current Control - ICC) à apresentada. Assim, para comprovaÃÃo da praticidade dos conversores apresentados, toma-se como base o conversor CA-CC de trÃs nÃveis convencional e entÃo à realizada uma anÃlise comparativa de desempenho entre esses trÃs conversores CA-CC monofÃsicos para aplicaÃÃo em no-breaks. Os conversores analisados possuem como caracterÃstica comum a correÃÃo do fator de potÃncia, o controle digital realizado por FPGA e a conexÃo da fonte de alimentaÃÃo com o estÃgio de saÃda, facilitando o uso de inversor e by-pass para no-breaks. O primeiro conversor analisado à o conversor de trÃs nÃveis convencional que apresenta como principal caracterÃstica o reduzido nÃmero de componentes. O segundo conversor analisado à o conversor de cinco nÃveis intercalado que apresenta como principal caracterÃstica as reduzidas perdas de comutaÃÃo e conduÃÃo. Finalmente, o terceiro conversor analisado à o conversor de cinco nÃveis tipo T que apresenta como principais caracterÃsticas: reduzidas perdas de comutaÃÃo e conduÃÃo; os elementos magnÃticos operam com o dobro da frequÃncia de comutaÃÃo reduzindo desta maneira o peso e o volume. A anÃlise teÃrica dos conversores monofÃsicos, os conceitos bÃsicos sobre o controle digital e a tÃcnica de modulaÃÃo, a metodologia de projeto, simulaÃÃo e resultados experimentais dos protÃtipos construÃdos sÃo apresentados para validar o princÃpio de funcionamento dos conversores propostos. / This thesis presents two novel topologies of AC-DC converters with common neutral: five-level interleaved converter and five-level T type converter. Besides, a novel type of implementation of Indirect Current Control (ICC) is also presented. Thus, a comparative analysis of performance between three single phase AC-DC converters for UPS applications is realized. The analyzed converters have as common characteristics: power factor correction, digital control using FPGA and connection between input power supply and converter output enabling the use of UPS inverter and by-pass. The first one analyzed converter is the conventional three level converter which presents as main feature reduced numbers of power semiconductors and components. The second one analyzed converter is the five level interleaving converter which presents as main feature reduced conduction and commutation losses. Finally, the last one analyzed converter is the T type five level converter which presents as main features: reduced conduction and commutation losses and magnetic components operating with the double of switching frequency reducing weight and volume. Theoretical analysis of the single phase converters, basics concepts of digital control and modulation technique, design procedure, simulation and experimental results of lab models are presented in order to validate the principle of operation of the proposed converters.

Les canaux de type T Cav3.2 sont des canaux calciques activés pour de faibles dépolarisations membranaires. Ils ont un rôle important dans la régulation de l’excitabilité neuronale, particulièrement dans les neurones des ganglions rachidiens dorsaux (DRG) où ils sont impliqués dans la transmission de la douleur. Il est établi que les canaux Cav3.2, natifs et recombinants, sont inhibés par de faibles concentrations de métaux divalents tels que le zinc et le nickel et qu’ils sont modulés par des agents oxydo-réducteurs. In vitro, la mutation ponctuelle de l’histidine 191 en glutamine (H191Q) diminue fortement la sensibilité du canal Cav3.2 pour ces différents composés et il est proposé que cette régulation joue un rôle physiologique. L’objectif de ce travail de thèse a été d’étudier l’impact physiologique de cette modulation sur l’excitabilité neuronale et dans la perception de la douleur. Pour ce faire, nous avons généré une souris knock-in (KI) portant la mutation H191Q sur Cav3.2. L’étude électrophysiologique a été réalisée sur une population de neurones de DRG particulière : les cellules D-hair qui sont des mécanorécepteurs exprimant de grands courants Cav3.2. Nous avons validé que la sensibilité des canaux Cav3.2 neuronaux des souris KI est diminuée pour le zinc, le nickel et l’ascorbate. Nous montrons que cette régulation modifiée favorise une augmentation de l’excitabilité de ces neurones. Pour étudier l’impact de cette modulation in vivo, nous avons effectué des études comportementales. Les souris KI ne présentent pas de différence dans la perception de la douleur mécanique et thermique, ni dans l’hyperalgésie induite par l’inflammation et la neuropathie. Toutefois, dans le test à la formaline les souris KI montrent une réponse exacerbée dans la phase tardive. En résumé, nous décrivons ici un modèle animal original pour l’étude de la régulation metal/redox du canal Cav3.2 et identifions un rôle de cette modulation dans l’excitabilité des neurones D-Hair. Nos résultats obtenus in vivo indiquent cependant que cette modulation des canaux Cav3.2 aurait un impact limité dans les voies de la douleur. / Cav3.2 T-type channels are low-voltage activated calcium channels. They have an important role in the regulation of neuronal excitability, particularly in neurons of the dorsal root ganglia (DRG) where they are involved in pain transmission. It is established that Cav3.2 channels are inhibited by low concentrations of divalent metals such as zinc and nickel, and are modulated by redox agents. In vitro, the histidine191-to-glutamine mutation (H191Q) greatly reduces the Cav3.2 channel sensitivity to these compounds and it is proposed that this regulation plays a physiological role. The objective of this thesis was to study the physiological impact of this modulation on neuronal excitability and pain perception. To do this, we generated a knock-in (KI) mouse carrying the H191Q mutation on Cav3.2. Electrophysiological study was carried out on a particular population of DRG neurons, the D-hair cells, which are mechanoreceptors that express large Cav3.2 currents. We show that the sensitivity to zinc, nickel and ascorbate of the neuronal Cav3.2 channels is significantly reduced in the KI mouse. We also show that this modified regulation promotes an increase in the excitability of these neurons. To study the impact of this modulation in vivo, we performed behavioral studies. KI mice show no difference in the perception of mechanical and thermal pain, nor in hyperalgesia induced by inflammation and neuropathy. However, KI mice show an exaggerated response in the late phase in the formalin test. In summary, we describe here an original animal model to study the metal/redox regulation of Cav3.2 channel and identify a role of this modulation in the excitability of D-Hair neurons. Our results indicate, however, that this modulation of Cav3.2 channel may have a limited impact in the pain pathways.